Stephanie Moy

Senior at EY

Speaker

Stephanie specializes in government pharmaceutical pricing programs and related compliance services for the pharmaceutical industry and for healthcare providers. She has experience conducting in-depth 340B Drug Pricing Program compliance assessments of large, multi-hospital health systems throughout the country, specifically targeting diversion, duplicate discount, and GPO prohibition violations. Stephanie has assisted with other Government Pricing compliance assessments and analytics under the Medicaid Drug Rebate Program (MDRP) and the Veterans Affairs (VA) Federal Supply Schedule (FSS), including assessments of manufacturer processes for calculating and reporting AMP, BP, and URA, FCP, and NFAMP values. She has also assisted in Independent Review Organization assessments of major pharmaceutical companies.